PUBLISHER: The Business Research Company | PRODUCT CODE: 1987715
PUBLISHER: The Business Research Company | PRODUCT CODE: 1987715
Embolization products are medical devices used to intentionally block or reduce blood flow in blood vessels. They help treat conditions such as aneurysms, arteriovenous malformations, and tumors by preventing blood supply to targeted areas. These products are designed to be biocompatible, safe, and effective for precise vascular interventions.
The primary categories of embolization products include coils, embolic agents, detachable balloons, liquid embolics, microcatheters, and guidewires. Embolization coils are flexible devices used to occlude blood vessels to control bleeding or restrict blood flow to aneurysms and tumors. Materials include metallic, polymeric, biological, and hybrid types. Technologies include bioresorbable and non-bioresorbable systems. Applications cover oncology, neurology, peripheral vascular disease, urology, and others, with use across hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs have impacted the embolization products market by increasing the cost of imported medical devices, raw materials, and specialized equipment. the rise in production and procurement costs has affected segments like embolic agents and detachable coils, particularly in regions such as north america and europe, which rely heavily on imports. while the tariffs pose challenges, they also encourage local manufacturing initiatives and innovation in cost-efficient embolization technologies, helping companies reduce dependency on global supply chains.
The embolization product market size has grown strongly in recent years. It will grow from $2.08 billion in 2025 to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising incidence of aneurysms and vascular malformations, growing adoption of minimally invasive procedures, increasing awareness of interventional radiology, rising demand for targeted cancer treatments, growing geriatric population requiring vascular interventions, increasing preference for outpatient procedures, rising healthcare infrastructure in emerging economies, growing focus on reducing surgical risks and complications, increasing technological advancements in embolization devices.
The embolization product market size is expected to see strong growth in the next few years. It will grow to $3.14 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to advancement in bioresorbable embolic materials, innovation in microcatheter-compatible devices, integration of image-guided navigation systems, advancement in liquid embolic agents, innovation in coil and plug designs, integration with robotic-assisted interventions, advancement in patient-specific device customization, innovation in minimally invasive delivery systems, integration of smart monitoring for real-time feedback, advancement in cost-effective manufacturing processes. Major trends in the forecast period include minimally invasive treatment adoption, personalized vascular therapies, advanced imaging integration, biocompatible material innovation, cost-effective embolization solutions.
The growing demand for minimally invasive treatment procedures is expected to drive the expansion of the embolization product market in the coming years. Minimally invasive procedures involve medical interventions with small incisions or catheter-based techniques, reducing trauma and allowing faster recovery compared with conventional surgeries. This rising preference for such treatments is fueling the use of embolization products, which play a vital role in procedures like controlling hemorrhages, managing vascular malformations, and treating tumors. Embolization products facilitate minimally invasive procedures by enabling physicians to accurately block abnormal blood flow to specific areas, lowering surgical risks, shortening recovery periods, and enhancing overall patient outcomes. For example, in August 2025, Dr. M. MacDonald reported that the global number of minimally invasive cosmetic procedures reached nearly 25.4 million in 2023, demonstrating a strong upward trend and broad adoption of less invasive medical interventions. Thus, the increasing demand for minimally invasive treatment procedures is propelling the growth of the embolization product market.
Major companies in the embolization products market are prioritizing the development of advanced microcatheter solutions, such as next-generation balloon occlusion devices, to enhance procedural efficiency, improve usability, and incorporate clinical feedback from physicians. Next-generation balloon occlusion microcatheters are minimally invasive tools designed to obstruct or reduce blood flow in specific blood vessels during embolization procedures, providing greater control, safety, and ease of operation. For example, in July 2025, Embolx, a US-based medical device company, introduced the Sniper G3 Balloon Occlusion Microcatheter. This third-generation device offers an extended shelf life, easier handling, and simplified preparation, directly addressing important feedback from physician users. It allows clinicians to perform targeted embolization procedures more efficiently, decreases procedural complexity, and enhances overall patient outcomes.
In February 2025, Stryker, a US-based global medical technology firm, acquired Inari Medical Inc. for an undisclosed sum. Through this acquisition, Stryker intends to broaden its interventional endovascular and embolization product offerings by incorporating Inari Medical's peripheral vascular technologies, improving treatment options for VTE and other vascular disorders. Inari Medical Inc. is a US-based medical device company focused on embolization products for minimally invasive vascular procedures.
Major companies operating in the embolization product market are Cardinal Health, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, MicroVention Inc., Terumo Corporation, Kaneka Corporation, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Guerbet Group, B. Braun Melsungen AG, Sirtex Medical Limited, Medikit Co. Ltd., Balt USA LLC, Acandis GmbH & Co. KG, ABK Biomedical Inc., CeloNova BioSciences, Shape Memory Medical Inc.
North America was the largest region in the embolization product market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolization product market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the embolization product market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The embolization product market consists of sales of coils, particles, liquid embolic agents, vascular plugs, gelatin sponges, and bioresorbable embolic materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The embolization product market research report is one of a series of new reports from The Business Research Company that provides embolization product market statistics, including embolization product industry global market size, regional shares, competitors with a embolization product market share, detailed embolization product market segments, market trends and opportunities, and any further data you may need to thrive in the embolization product industry. This embolization product market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Embolization Product Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses embolization product market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for embolization product ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The embolization product market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.